Early high plasma ST2, the decoy IL-33 receptor, in children undergoing hematopoietic cell transplantation is associated with the development of post-transplant diabetes mellitus

Haematologica. 2020 May;105(5):e249-e252. doi: 10.3324/haematol.2019.222992. Epub 2019 Aug 29.

Authors

Courtney M Rowan¹, Alicia M Teagarden², Daniel T Cater², Elizabeth A S Moser³, Giorgos Baykoyannis³, Sophie Paczesny¹

Affiliations

¹ Department of Pediatrics, Indiana University School of Medicine coujohns@iu.edu sophpacz@iu.edu.
² Department of Pediatrics, Indiana University School of Medicine.
³ Department of Biostatistics, Indiana University, Indianapolis, IN, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Child
Diabetes Mellitus*
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Interleukin-33
Plasma
Receptors, Interleukin / blood*

Substances

Interleukin-33
Receptors, Interleukin

Grants and funding